AstraZeneca develops a treatment for stomach cancer
An-Nahar: AstraZeneca’s Sone-ve drug shows an improvement in survival time for patients with advanced stomach cancer, with a 53% reduction in the risk of death, according to a recent clinical trial whose results were presented during…




























